Everand Logo

Welcome to Everand!

  • STAT

    On Instagram, plastic surgery promotions aren’t always what they seem

    A potential risk in user-driven photo advertising is the difficulty in discerning quality plastic surgery providers from uncertified or unscrupulous ones.
    by Kate Sheridan Aug 30, 2017 3 minutes

    Instagram is increasingly being used as an advertising platform for people and companies hawking medications, supplements, and even so-called “detox” teas. Occasionally, those advertisements cross the line; in 2015, the FDA warned one company about Kim Kardashian’s Instagram posts promoting its drug to treat morning sickness.

    But findings in a new paper reveal another potential risk in user-driven photo advertising — a difficulty in discerning quality plastic surgery providers from uncertified or unscrupulous ones.

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
    The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About Wegovy And Ozempic Sales, Rising Pharma Layoffs, And More
    Sales of the blockbuster Wegovy obesity treatment more than doubled in the first quarter as Novo Nordisk races to make more of the drug to meet surging demand.
    STAT2 min readAmerican Government
    STAT+: Pharmalittle: We’re Reading About FTC Reviewing Novo-Catalent Deal, Amneal Opioid Settlement, And More
    The FTC wants more information on a $16.5 million deal in which Novo Nordisk's parent company would purchase Catalent, a contract drug manufacturer.

    Related Books & Audiobooks